Dual Adaptation and Adaptive Generalization of the Human Vestibulo-Ocular Reflex

In two experiments, we examined the possibility that the human vestibulo-ocular reflex (VOR) is subject to dual adaptation (the ability to adapt to a sensory rearrangement more rapidly and/or more completely after repeated experience with it) and adaptive generalization (the ability to adapt more readily to a novel sensory rearrangement as a result of prior dual adaptation training). In Experiment 1, the subjects actively turned the head during alternating exposure to a visual-vestibular rearrangement (target/head gain = 0.5) and the normal situation (target/head gain = 0.0). These conditions produced both adaptation and dual adaptation of the VOR but no evidence of adaptive generalization when tested with a target/head gain of 1.0. Experiment 2, in which exposure to the 0.5 gain entailed externally controlled (i.e., passive) whole body rotation, resulted in VOR adaptation but no dual adaptation. As in Experiment 1, no evidence of adaptive generalization was found

An analytic model for a cooperative ballistic deposition in one dimension

We formulate a model for a cooperative ballistic deposition (CBD) process whereby the incoming particles are correlated with the ones already adsorbed via attractive force. The strength of the correlation is controlled by a tunable parameter $a$ that interpolates the classical car parking problem at $a=0$, the ballistic deposition at $a=1$ and the CBD model at $a>1$. The effects of the correlation in the CBD model are as follows. The jamming coverage $q(a)$ increases with the strength of attraction $a$ due to an ever increasing tendency of cluster formation. The system almost reaches the closest packing structure as $a\to\infty$ but never forms a percolating cluster which is typical to 1D system. In the large $a$ regime, the mean cluster size $k$ increases as $a^{1/2}$. Furthermore, the asymptotic approach towards the closest packing is purely algebraic both with $a$ as $q(\infty)-q(a) \sim a^{-1/2}$ and with $k$ as $q(\infty)-q(k) \sim k^{-1}$ where $q(\infty)\simeq 1$.Comment: 9 pages (in Revtex4), 9 eps figures; Submitted to publicatio

Inner ear tissue preservation by rapid freezing: improving fixation by high-pressure freezing and hybrid methods

In the preservation of tissues in as ‘close to life’ state as possible, rapid freeze fixation has many benefits over conventional chemical fixation. One technique by which rapid freeze-fixation can be achieved, high pressure freezing (HPF), has been shown to enable ice crystal artefact-free freezing and tissue preservation to greater depths (more than 40μm) than other quick-freezing methods. Despite increasingly becoming routine in electron microscopy, the use of HPF for the fixation of inner ear tissue has been limited. Assessment of the quality of preservation showed routine HPF techniques were suitable for preparation of inner ear tissues in a variety of species. Good preservation throughout the depth of sensory epithelia was achievable. Comparison to chemically fixed tissue indicated that fresh frozen preparations exhibited overall superior structural preservation of cells. However, HPF fixation caused characteristic artefacts in stereocilia that suggested poor quality freezing of the actin bundles. The hybrid technique of pre-fixation and high pressure freezing was shown to produce cellular preservation throughout the tissue, similar to that seen in HPF alone. Pre-fixation HPF produced consistent high quality preservation of stereociliary actin bundles. Optimising the preparation of samples with minimal artefact formation allows analysis of the links between ultrastructure and function in inner ear tissues

The selective phosphodiesterase 4 inhibitor roflumilast and phosphodiesterase 3/4 inhibitor pumafentrine reduce clinical score and TNF expression in experimental colitis in mice.

The specific inhibition of phosphodiesterase (PDE)4 and dual inhibition of PDE3 and PDE4 has been shown to decrease inflammation by suppression of pro-inflammatory cytokine synthesis. We examined the effect of roflumilast, a selective PDE4 inhibitor marketed for severe COPD, and the investigational compound pumafentrine, a dual PDE3/PDE4 inhibitor, in the preventive dextran sodium sulfate (DSS)-induced colitis model. The clinical score, colon length, histologic score and colon cytokine production from mice with DSS-induced colitis (3.5% DSS in drinking water for 11 days) receiving either roflumilast (1 or 5 mg/kg body weight/d p.o.) or pumafentrine (1.5 or 5 mg/kg/d p.o.) were determined and compared to vehicle treated control mice. In the pumafentrine-treated animals, splenocytes were analyzed for interferon-γ (IFNγ) production and CD69 expression. Roflumilast treatment resulted in dose-dependent improvements of clinical score (weight loss, stool consistency and bleeding), colon length, and local tumor necrosis factor-α (TNFα) production in the colonic tissue. These findings, however, were not associated with an improvement of the histologic score. Administration of pumafentrine at 5 mg/kg/d alleviated the clinical score, the colon length shortening, and local TNFα production. In vitro stimulated splenocytes after in vivo treatment with pumafentrine showed a significantly lower state of activation and production of IFNγ compared to no treatment in vivo. These series of experiments document the ameliorating effect of roflumilast and pumafentrine on the clinical score and TNF expression of experimental colitis in mice

Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease

INTRODUCTION: We aimed to explore the prevalence of portal hypertension in the most common etiologies of patients with compensated advanced chronic liver disease (cACLD) and develop classification rules, based on liver stiffness measurement (LSM), that could be readily used to diagnose or exclude clinically significant portal hypertension (CSPH) in clinical practice. METHODS: This is an international cohort study including patients with paired LSM/hepatic venous pressure gradient (HVPG), LSM ≥10 kPa, and no previous decompensation. Portal hypertension was defined by an HVPG >5 mm Hg. A positive predictive value ≥90% was considered to validate LSM cutoffs for CSPH (HVPG ≥10 mm Hg), whereas a negative predictive value ≥90% ruled out CSPH. RESULTS: A total of 836 patients with hepatitis C (n = 358), nonalcoholic steatohepatitis (NASH, n = 248), alcohol use (n = 203), and hepatitis B (n = 27) were evaluated. Portal hypertension prevalence was >90% in all cACLD etiologies, except for patients with NASH (60.9%), being even lower in obese patients with NASH (53.3%); these lower prevalences of portal hypertension in patients with NASH were maintained across different strata of LSM values. LSM ≥25 kPa was the best cutoff to rule in CSPH in alcoholic liver disease, chronic hepatitis B, chronic hepatitis C, and nonobese patients with NASH, whereas in obese NASH patients, the positive predictive value was only 62.8%. A new model for patients with NASH (ANTICIPATE-NASH model) to predict CSPH considering body mass index, LSM, and platelet count was developed, and a nomogram was constructed. LSM ≤15 kPa plus platelets ≥150 × 10/L ruled out CSPH in most etiologies. DISCUSSION: Patients with cACLD of NASH etiology, especially obese patients with NASH, present lower prevalences of portal hypertension compared with other cACLD etiologies. LSM ≥25 kPa is sufficient to rule in CSPH in most etiologies, including nonobese patients with NASH, but not in obese patients with NASH

Search for Bs0→γγB_{s}^{0}\rightarrow\gamma\gamma and a measurement of the branching fraction for Bs0→ϕγB_{s}^{0}\rightarrow\phi\gamma

We search for the decay $B_{s}^{0}\rightarrow\gamma\gamma$ and measure the branching fraction for $B_{s}^{0}\rightarrow\phi\gamma$ using 121.4~$\textrm{fb}^{-1}$ of data collected at the $\Upsilon(\mathrm{5}S)$ resonance with the Belle detector at the KEKB asymmetric-energy $e^{+}e^{-}$ collider. The $B_{s}^{0}\rightarrow\phi\gamma$ branching fraction is measured to be $(3.6 \pm 0.5 (\mathrm{stat.}) \pm 0.3 (\mathrm{syst.}) \pm 0.6 (f_{s})) \times 10^{-5}$, where $f_{s}$ is the fraction of $B_{s}^{(*)}\bar{B}_{s}^{(*)}$ in $b\bar{b}$ events. Our result is in good agreement with the theoretical predictions as well as with a recent measurement from LHCb. We observe no statistically significant signal for the decay $B_{s}^{0}\rightarrow\gamma\gamma$ and set a $90\%$ confidence-level upper limit on its branching fraction at $3.1 \times 10^{-6}$. This constitutes a significant improvement over the previous result.Comment: 6 pages, 3 figure

Correlated electrons in the presence of disorder

Several new aspects of the subtle interplay between electronic correlations and disorder are reviewed. First, the dynamical mean-field theory (DMFT)together with the geometrically averaged ("typical") local density of states is employed to compute the ground state phase diagram of the Anderson-Hubbard model at half-filling. This non-perturbative approach is sensitive to Anderson localization on the one-particle level and hence can detect correlated metallic, Mott insulating and Anderson insulating phases and can also describe the competition between Anderson localization and antiferromagnetism. Second, we investigate the effect of binary alloy disorder on ferromagnetism in materials with $f$-electrons described by the periodic Anderson model. A drastic enhancement of the Curie temperature $T_c$ caused by an increase of the local $f$-moments in the presence of disordered conduction electrons is discovered and explained.Comment: 17 pages, 7 figures, final version, typos corrected, references updated, submitted to Eur. Phys. J. for publication in the Special Topics volume "Cooperative Phenomena in Solids: Metal-Insulator Transitions and Ordering of Microscopic Degrees of Freedom

First observation of the hadronic transition Υ(4S)→ηhb(1P) \Upsilon(4S) \to \eta h_{b}(1P) and new measurement of the hb(1P)h_b(1P) and ηb(1S)\eta_b(1S) parameters

Using a sample of $771.6 \times 10^{6}$ $\Upsilon(4S)$ decays collected by the Belle experiment at the KEKB $e^+e^-$ collider, we observe for the first time the transition $\Upsilon(4S) \to \eta h_b(1P)$ with the branching fraction ${\cal B}[\Upsilon(4S) \to \eta h_b(1P)]= (2.18 \pm 0.11 \pm 0.18) \times 10^{-3}$ and we measure the $h_b(1P)$ mass $M_{h_{b}(1P)} = (9899.3 \pm 0.4 \pm 1.0)$ MeV/$c^{2}$, corresponding to the hyperfine splitting $\Delta M_{\mathrm HF}(1P) = (0.6 \pm 0.4 \pm 1.0)$ MeV/$c^{2}$. Using the transition $h_b(1P) \to \gamma \eta_b(1S)$, we measure the $\eta_b(1S)$ mass $M_{\eta_{b}(1S)} = (9400.7 \pm 1.7 \pm 1.6)$ MeV/$c^{2}$, corresponding to $\Delta M_{\mathrm HF}(1S) = (59.6 \pm 1.7 \pm 1.6)$ MeV/$c^{2}$, the $\eta_b(1S)$ width $\Gamma_{\eta_{b}(1S)} = (8 ^{+6}_{-5} \pm 5)$ MeV/$c^{2}$ and the branching fraction ${\cal B}[h_b(1P) \to \gamma \eta_b(1S)]= (56 \pm 8 \pm 4) \%$.Comment: 7 pages, 2 figures, submitted to Phys. Rev. Let

Study of e+e- => B(*) B(*)-bar pi+- at sqrt(s)=10.866 GeV

We report the analysis of the three-body e+e- => B B-bar pi, B B*-bar pi, and B* B*-bar pi processes, including the first observation of the Zb+-(10610) =>[B B*-bar+c.c.]+- and Zb+-(10650) => [B*B*-bar]+- transitions. We measure visible cross sections for the three-body production of sigma_vis(e+e- => [B B*-bar+c.c.]+-pi-+=(11.2+-1.0(stat.)+-1.2(syst.)) pb and sigma_vis(e+e- => [B*B*-bar]+-pi-+)=(5.61+-0.73(stat.)+-0.66(syst.)) pb and set a 90% C.L. upper limit of sigma_vis(e+e- => [BB-bar]+-pi-+)<2.1 pb. The results are based on a 121.4 1/fb data sample collected with the Belle detector at a center-of-mass energy near the Y(5S) peak.Comment: 8 pages, 2 figure